510(k) Report

510(k) · Cleared

Cleared

Prima System - Old, Bartels Elisa - New

K990664510(k) SpecialCleared Mar 31, 199930-day reviewClass I21 CFR 866.2660

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Intracel Corp. · LLH Reagents, Clostridium Difficile Toxin

Cleared on Mar 31, 1999 as substantially equivalent to K913229 (Baxter Diagnostics, Inc., 1991) after a 30-day review. Its family tree reaches back 1 generation to 1991.

Decided
Mar 31, 1999
Review
30 days
Class
Class I
Product code
LLH
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K913229 (1991). No later device cites it as a predicate yet.

K913229 · Bartels Clostridium Difficile Toxin a Enzym Immun · Baxter Diagnostics, Inc. · 1991199019921994199619982000
  1. Root · 1 generation backK913229 Bartels Clostridium Difficile Toxin a Enzym ImmunBaxter Diagnostics, Inc. · 1991
  2. This deviceK990664 Prima System - Old, Bartels Elisa - NewIntracel Corp. · 1999
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K913229Bartels Clostridium Difficile Toxin a Enzym ImmunBaxter Diagnostics, Inc.1991—
0 (this device)K990664Prima System - Old, Bartels Elisa - NewIntracel Corp.1999—
FIG. 1 — Lineage of K990664, 1991–1999Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LLH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LLH device

  1. #1 K193490 SensiTox C. difficile Toxin Testscore 1.6 · 1 generation · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K913229Bartels Clostridium Difficile Toxin a Enzym Immun
Summary page 1
…ls PRIMA System™ Clostridium difficile Toxin A Enzyme Immunoassay (EIA). Trade/Proprietary Name: PRIMA System — old Bartels ELISA - new Device Class: Class | 510(k): K913229 F:\Submissions\510K\Improved C ditticile EIA\510(k)K990664amendment031999.doc INTRACEL Corporation 03/19/99 (e…
Baxter Diagnostics, Inc.1991—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All LLH devices

LLH Reagents, Clostridium Difficile Toxin: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LLH

1in 2021

2007: 12008: 22009: 32010: 12021: 1
2007high 3 (2009) · low 0 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LLH

84in 2009

2009: 84 days median
2007high 84 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LLH

1in 2021

2010: 12012: 22013: 22021: 1
2007high 2 (2012) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LLH

1in 2025

2010: 12021: 12022: 12023: 12024: 12025: 1
2007high 1 (2010) · low 0 (2007)2025

MAUDE reports naming product code LLH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20082—00
200938400
20101—11
20110—00
20120—20
20130—20
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20211—11
20220—01
20230—01
20240—01
20250—01
20260—0—

What is it indicated for?

Bartels Clostridium difficille Toxin A Enzyme Immunoassay (EIA) is intended for the qualitative detection of Clostridium difficille Toxin A in human fecal specimens as an aid in the diagnosis of Clostridium difficille-associated disease.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K990664: Prima System - Old, Bartels Elisa - New.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K990664

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026